[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Innovative Drug Market Growth (Status and Outlook) 2023-2029

March 2023 | 113 pages | ID: GD1A54A52F51EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Innovative drugs refer to drugs with proprietary intellectual property rights.

LPI (LP Information)' newest research report, the “Innovative Drug Industry Forecast” looks at past sales and reviews total world Innovative Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Innovative Drug sales for 2023 through 2029. With Innovative Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Innovative Drug industry.

This Insight Report provides a comprehensive analysis of the global Innovative Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Innovative Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Innovative Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Innovative Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Innovative Drug.

The global Innovative Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Innovative Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Innovative Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Innovative Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Innovative Drug players cover Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Innovative Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Biological Medicine
  • Chemical Medicine
Segmentation by application
  • Hospitals and Clinics
  • Pharmacy
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Pfizer
  • Roche
  • Sanofi
  • Johnson & Johnson
  • Merck & Co. (MSD)
  • Novartis
  • AbbVie
  • Gilead Sciences
  • GlaxoSmithKline (GSK)
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Eli Lilly
  • Teva
  • Bayer
  • Novo Nordisk
  • Allergan
  • Takeda
  • Boehringer Ingelheim
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Innovative Drug Market Size 2018-2029
  2.1.2 Innovative Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Innovative Drug Segment by Type
  2.2.1 Biological Medicine
  2.2.2 Chemical Medicine
2.3 Innovative Drug Market Size by Type
  2.3.1 Innovative Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Innovative Drug Market Size Market Share by Type (2018-2023)
2.4 Innovative Drug Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Pharmacy
  2.4.3 Others
2.5 Innovative Drug Market Size by Application
  2.5.1 Innovative Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Innovative Drug Market Size Market Share by Application (2018-2023)

3 INNOVATIVE DRUG MARKET SIZE BY PLAYER

3.1 Innovative Drug Market Size Market Share by Players
  3.1.1 Global Innovative Drug Revenue by Players (2018-2023)
  3.1.2 Global Innovative Drug Revenue Market Share by Players (2018-2023)
3.2 Global Innovative Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INNOVATIVE DRUG BY REGIONS

4.1 Innovative Drug Market Size by Regions (2018-2023)
4.2 Americas Innovative Drug Market Size Growth (2018-2023)
4.3 APAC Innovative Drug Market Size Growth (2018-2023)
4.4 Europe Innovative Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Innovative Drug Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Innovative Drug Market Size by Country (2018-2023)
5.2 Americas Innovative Drug Market Size by Type (2018-2023)
5.3 Americas Innovative Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Innovative Drug Market Size by Region (2018-2023)
6.2 APAC Innovative Drug Market Size by Type (2018-2023)
6.3 APAC Innovative Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Innovative Drug by Country (2018-2023)
7.2 Europe Innovative Drug Market Size by Type (2018-2023)
7.3 Europe Innovative Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Innovative Drug by Region (2018-2023)
8.2 Middle East & Africa Innovative Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Innovative Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INNOVATIVE DRUG MARKET FORECAST

10.1 Global Innovative Drug Forecast by Regions (2024-2029)
  10.1.1 Global Innovative Drug Forecast by Regions (2024-2029)
  10.1.2 Americas Innovative Drug Forecast
  10.1.3 APAC Innovative Drug Forecast
  10.1.4 Europe Innovative Drug Forecast
  10.1.5 Middle East & Africa Innovative Drug Forecast
10.2 Americas Innovative Drug Forecast by Country (2024-2029)
  10.2.1 United States Innovative Drug Market Forecast
  10.2.2 Canada Innovative Drug Market Forecast
  10.2.3 Mexico Innovative Drug Market Forecast
  10.2.4 Brazil Innovative Drug Market Forecast
10.3 APAC Innovative Drug Forecast by Region (2024-2029)
  10.3.1 China Innovative Drug Market Forecast
  10.3.2 Japan Innovative Drug Market Forecast
  10.3.3 Korea Innovative Drug Market Forecast
  10.3.4 Southeast Asia Innovative Drug Market Forecast
  10.3.5 India Innovative Drug Market Forecast
  10.3.6 Australia Innovative Drug Market Forecast
10.4 Europe Innovative Drug Forecast by Country (2024-2029)
  10.4.1 Germany Innovative Drug Market Forecast
  10.4.2 France Innovative Drug Market Forecast
  10.4.3 UK Innovative Drug Market Forecast
  10.4.4 Italy Innovative Drug Market Forecast
  10.4.5 Russia Innovative Drug Market Forecast
10.5 Middle East & Africa Innovative Drug Forecast by Region (2024-2029)
  10.5.1 Egypt Innovative Drug Market Forecast
  10.5.2 South Africa Innovative Drug Market Forecast
  10.5.3 Israel Innovative Drug Market Forecast
  10.5.4 Turkey Innovative Drug Market Forecast
  10.5.5 GCC Countries Innovative Drug Market Forecast
10.6 Global Innovative Drug Forecast by Type (2024-2029)
10.7 Global Innovative Drug Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Innovative Drug Product Offered
  11.1.3 Pfizer Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Innovative Drug Product Offered
  11.2.3 Roche Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Innovative Drug Product Offered
  11.3.3 Sanofi Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Innovative Drug Product Offered
  11.4.3 Johnson & Johnson Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments
11.5 Merck & Co. (MSD)
  11.5.1 Merck & Co. (MSD) Company Information
  11.5.2 Merck & Co. (MSD) Innovative Drug Product Offered
  11.5.3 Merck & Co. (MSD) Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Merck & Co. (MSD) Main Business Overview
  11.5.5 Merck & Co. (MSD) Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis Innovative Drug Product Offered
  11.6.3 Novartis Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 AbbVie
  11.7.1 AbbVie Company Information
  11.7.2 AbbVie Innovative Drug Product Offered
  11.7.3 AbbVie Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 AbbVie Main Business Overview
  11.7.5 AbbVie Latest Developments
11.8 Gilead Sciences
  11.8.1 Gilead Sciences Company Information
  11.8.2 Gilead Sciences Innovative Drug Product Offered
  11.8.3 Gilead Sciences Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Gilead Sciences Main Business Overview
  11.8.5 Gilead Sciences Latest Developments
11.9 GlaxoSmithKline (GSK)
  11.9.1 GlaxoSmithKline (GSK) Company Information
  11.9.2 GlaxoSmithKline (GSK) Innovative Drug Product Offered
  11.9.3 GlaxoSmithKline (GSK) Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 GlaxoSmithKline (GSK) Main Business Overview
  11.9.5 GlaxoSmithKline (GSK) Latest Developments
11.10 Amgen
  11.10.1 Amgen Company Information
  11.10.2 Amgen Innovative Drug Product Offered
  11.10.3 Amgen Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Amgen Main Business Overview
  11.10.5 Amgen Latest Developments
11.11 AstraZeneca
  11.11.1 AstraZeneca Company Information
  11.11.2 AstraZeneca Innovative Drug Product Offered
  11.11.3 AstraZeneca Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 AstraZeneca Main Business Overview
  11.11.5 AstraZeneca Latest Developments
11.12 Bristol-Myers Squibb
  11.12.1 Bristol-Myers Squibb Company Information
  11.12.2 Bristol-Myers Squibb Innovative Drug Product Offered
  11.12.3 Bristol-Myers Squibb Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Bristol-Myers Squibb Main Business Overview
  11.12.5 Bristol-Myers Squibb Latest Developments
11.13 Eli Lilly
  11.13.1 Eli Lilly Company Information
  11.13.2 Eli Lilly Innovative Drug Product Offered
  11.13.3 Eli Lilly Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Eli Lilly Main Business Overview
  11.13.5 Eli Lilly Latest Developments
11.14 Teva
  11.14.1 Teva Company Information
  11.14.2 Teva Innovative Drug Product Offered
  11.14.3 Teva Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Teva Main Business Overview
  11.14.5 Teva Latest Developments
11.15 Bayer
  11.15.1 Bayer Company Information
  11.15.2 Bayer Innovative Drug Product Offered
  11.15.3 Bayer Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Bayer Main Business Overview
  11.15.5 Bayer Latest Developments
11.16 Novo Nordisk
  11.16.1 Novo Nordisk Company Information
  11.16.2 Novo Nordisk Innovative Drug Product Offered
  11.16.3 Novo Nordisk Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Novo Nordisk Main Business Overview
  11.16.5 Novo Nordisk Latest Developments
11.17 Allergan
  11.17.1 Allergan Company Information
  11.17.2 Allergan Innovative Drug Product Offered
  11.17.3 Allergan Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 Allergan Main Business Overview
  11.17.5 Allergan Latest Developments
11.18 Takeda
  11.18.1 Takeda Company Information
  11.18.2 Takeda Innovative Drug Product Offered
  11.18.3 Takeda Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 Takeda Main Business Overview
  11.18.5 Takeda Latest Developments
11.19 Boehringer Ingelheim
  11.19.1 Boehringer Ingelheim Company Information
  11.19.2 Boehringer Ingelheim Innovative Drug Product Offered
  11.19.3 Boehringer Ingelheim Innovative Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Boehringer Ingelheim Main Business Overview
  11.19.5 Boehringer Ingelheim Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Innovative Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Biological Medicine
Table 3. Major Players of Chemical Medicine
Table 4. Innovative Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Innovative Drug Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Innovative Drug Market Size Market Share by Type (2018-2023)
Table 7. Innovative Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Innovative Drug Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Innovative Drug Market Size Market Share by Application (2018-2023)
Table 10. Global Innovative Drug Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Innovative Drug Revenue Market Share by Player (2018-2023)
Table 12. Innovative Drug Key Players Head office and Products Offered
Table 13. Innovative Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Innovative Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Innovative Drug Market Size Market Share by Regions (2018-2023)
Table 18. Global Innovative Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Innovative Drug Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Innovative Drug Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Innovative Drug Market Size Market Share by Country (2018-2023)
Table 22. Americas Innovative Drug Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Innovative Drug Market Size Market Share by Type (2018-2023)
Table 24. Americas Innovative Drug Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Innovative Drug Market Size Market Share by Application (2018-2023)
Table 26. APAC Innovative Drug Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Innovative Drug Market Size Market Share by Region (2018-2023)
Table 28. APAC Innovative Drug Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Innovative Drug Market Size Market Share by Type (2018-2023)
Table 30. APAC Innovative Drug Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Innovative Drug Market Size Market Share by Application (2018-2023)
Table 32. Europe Innovative Drug Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Innovative Drug Market Size Market Share by Country (2018-2023)
Table 34. Europe Innovative Drug Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Innovative Drug Market Size Market Share by Type (2018-2023)
Table 36. Europe Innovative Drug Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Innovative Drug Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Innovative Drug Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Innovative Drug Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Innovative Drug Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Innovative Drug Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Innovative Drug Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Innovative Drug Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Innovative Drug
Table 45. Key Market Challenges & Risks of Innovative Drug
Table 46. Key Industry Trends of Innovative Drug
Table 47. Global Innovative Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Innovative Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Innovative Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Innovative Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Pfizer Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 52. Pfizer Innovative Drug Product Offered
Table 53. Pfizer Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Roche Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 57. Roche Innovative Drug Product Offered
Table 58. Roche Main Business
Table 59. Roche Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Roche Latest Developments
Table 61. Sanofi Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 62. Sanofi Innovative Drug Product Offered
Table 63. Sanofi Main Business
Table 64. Sanofi Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Sanofi Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 67. Johnson & Johnson Innovative Drug Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Johnson & Johnson Latest Developments
Table 71. Merck & Co. (MSD) Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 72. Merck & Co. (MSD) Innovative Drug Product Offered
Table 73. Merck & Co. (MSD) Main Business
Table 74. Merck & Co. (MSD) Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Merck & Co. (MSD) Latest Developments
Table 76. Novartis Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 77. Novartis Innovative Drug Product Offered
Table 78. Novartis Main Business
Table 79. Novartis Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Novartis Latest Developments
Table 81. AbbVie Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 82. AbbVie Innovative Drug Product Offered
Table 83. AbbVie Main Business
Table 84. AbbVie Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. AbbVie Latest Developments
Table 86. Gilead Sciences Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 87. Gilead Sciences Innovative Drug Product Offered
Table 88. Gilead Sciences Main Business
Table 89. Gilead Sciences Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Gilead Sciences Latest Developments
Table 91. GlaxoSmithKline (GSK) Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 92. GlaxoSmithKline (GSK) Innovative Drug Product Offered
Table 93. GlaxoSmithKline (GSK) Main Business
Table 94. GlaxoSmithKline (GSK) Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. GlaxoSmithKline (GSK) Latest Developments
Table 96. Amgen Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 97. Amgen Innovative Drug Product Offered
Table 98. Amgen Main Business
Table 99. Amgen Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Amgen Latest Developments
Table 101. AstraZeneca Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 102. AstraZeneca Innovative Drug Product Offered
Table 103. AstraZeneca Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. Bristol-Myers Squibb Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 107. Bristol-Myers Squibb Innovative Drug Product Offered
Table 108. Bristol-Myers Squibb Main Business
Table 109. Bristol-Myers Squibb Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Bristol-Myers Squibb Latest Developments
Table 111. Eli Lilly Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 112. Eli Lilly Innovative Drug Product Offered
Table 113. Eli Lilly Main Business
Table 114. Eli Lilly Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Eli Lilly Latest Developments
Table 116. Teva Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 117. Teva Innovative Drug Product Offered
Table 118. Teva Main Business
Table 119. Teva Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Teva Latest Developments
Table 121. Bayer Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 122. Bayer Innovative Drug Product Offered
Table 123. Bayer Main Business
Table 124. Bayer Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Bayer Latest Developments
Table 126. Novo Nordisk Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 127. Novo Nordisk Innovative Drug Product Offered
Table 128. Novo Nordisk Main Business
Table 129. Novo Nordisk Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Novo Nordisk Latest Developments
Table 131. Allergan Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 132. Allergan Innovative Drug Product Offered
Table 133. Allergan Main Business
Table 134. Allergan Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Allergan Latest Developments
Table 136. Takeda Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 137. Takeda Innovative Drug Product Offered
Table 138. Takeda Main Business
Table 139. Takeda Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Takeda Latest Developments
Table 141. Boehringer Ingelheim Details, Company Type, Innovative Drug Area Served and Its Competitors
Table 142. Boehringer Ingelheim Innovative Drug Product Offered
Table 143. Boehringer Ingelheim Main Business
Table 144. Boehringer Ingelheim Innovative Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Boehringer Ingelheim Latest Developments

LIST OF FIGURES

Figure 1. Innovative Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Innovative Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Innovative Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Innovative Drug Sales Market Share by Country/Region (2022)
Figure 8. Innovative Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Innovative Drug Market Size Market Share by Type in 2022
Figure 10. Innovative Drug in Hospitals and Clinics
Figure 11. Global Innovative Drug Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 12. Innovative Drug in Pharmacy
Figure 13. Global Innovative Drug Market: Pharmacy (2018-2023) & ($ Millions)
Figure 14. Innovative Drug in Others
Figure 15. Global Innovative Drug Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Innovative Drug Market Size Market Share by Application in 2022
Figure 17. Global Innovative Drug Revenue Market Share by Player in 2022
Figure 18. Global Innovative Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Innovative Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Innovative Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Innovative Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Innovative Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Innovative Drug Value Market Share by Country in 2022
Figure 24. United States Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Innovative Drug Market Size Market Share by Region in 2022
Figure 29. APAC Innovative Drug Market Size Market Share by Type in 2022
Figure 30. APAC Innovative Drug Market Size Market Share by Application in 2022
Figure 31. China Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Innovative Drug Market Size Market Share by Country in 2022
Figure 38. Europe Innovative Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Innovative Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Innovative Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Innovative Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Innovative Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Innovative Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Innovative Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Innovative Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Innovative Drug Market Size Market Share Forecast by Application (2024-2029)


More Publications